NeuroCycle Therapeutics uses the latest neuroscience research from leading academic experts to discover and develop new CNS drugs. Our focus is to selectively modulate neuronal ion channels. This allows us to control dysfunctional neuronal activity without undesirable side effects. Our initial interest is in receptors for the inhibitory neurotransmitters γ-aminobutyric acid (GABA). Imbalances towards excessive neuronal excitation leads to a variety of disorders, and our aim is to restore balance by selective inhibition at the site of imbalance.